Accenture PLC Stock Forecast for 2023 - 2025 - 2030
Updated on 03/18/2024
Accenture PLC Stock Forecast and Price Target
Accenture PLC has an average price target of $375.00 recently offered by thridteen notable experts for 2024, which would represent a potential upside of approximately 0.48% from the last closing price in March, 2024 if reached. This potential increase is based on a high estimate of $440.00 and a low estimate of $271.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
0.48% Upside
Accenture PLC Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Accenture PLC's Price has fallen from $208.58 to $0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach $371.87 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
EXPO Stock Forecast | Exponent | Outperform |
18
|
$79.48 | Buy/Sell | $100.50 | 11.35% |
ICFI Stock Forecast | ICF International | Outperform |
16
|
$153.65 | Buy/Sell | $150.75 | 12.59% |
HURN Stock Forecast | Huron Consulting Group | Buy |
15
|
$99.35 | Buy/Sell | $132.67 | 40.92% |
HCKT Stock Forecast | The Hackett Group | Outperform |
18
|
$24.79 | Buy/Sell | $27.00 | 12.95% |
RGP Stock Forecast | Resources Connection | Hold |
18
|
$13.73 | Buy/Sell | $16.00 | 9.25% |
Accenture PLC Revenue Forecast for 2023 - 2025 - 2030
Accenture PLC's Revenue has increased by 44.63% In the last three years, going from $44.33B to $64.11B. In the next year, analysts expect Revenue to reach $73.56B – an increase of 14.74%. For the next seven years, the forecast is for Revenue to grow by 27.46%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
CHMX Stock Forecast | NEXT-ChemX | - |
4
|
$9.02 | Buy/Sell | $0.00 | -100.00% |
SKIL Stock Forecast | Skillsoft | Outperform |
4
|
$11.81 | Buy/Sell | $45.33 | 238.70% |
SHWZ Stock Forecast | Medicine Man Technologies | Buy |
12
|
$1.00 | Buy/Sell | $3.06 | 200.00% |
Accenture PLC Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Accenture PLC's Dividend per Share has grown, increasing from $3.28 to $4.65 – a growth of 41.77%. In the following year, 11 experts forecast Accenture PLC's Dividend per Share will decrease by 3.66%, to $4.48. Over the next seven years, experts anticipate that Accenture PLC's Dividend per Share will grow at a rate of 8.20%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
WSCO Stock Forecast | Global AI | - |
0
|
$0.48 | Buy/Sell | $0.00 | -100.00% |
FLNT Stock Forecast | Fluent | Hold |
15
|
$0.56 | Buy/Sell | $2.00 | 257.14% |
PBSV Stock Forecast | Pharma-Bio Serv | - |
0
|
$0.90 | Buy/Sell | $1.81 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ARGC Stock Forecast | Arion Group | - |
0
|
$2.50 | Buy/Sell | $0.00 | -100.00% |
NUKK Stock Forecast | Nukkleus | - |
2
|
$1.15 | Buy/Sell | $0.00 | -100.00% |
PNPL Stock Forecast | Pineapple | - |
0
|
$0.06 | Buy/Sell | $0.00 | -100.00% |
Accenture PLC EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Accenture PLC's EBITDA has grown from $7.24B to $11.20B – a 54.77% increase. Next year, analysts are expecting EBITDA to reach $13.86B – an increase of 23.75%. Over the next seven years, the forecast is for EBITDA to grow by 34.07%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
CANN Stock Forecast | Trees | - |
0
|
$0.08 | Buy/Sell | $0.00 | -100.00% |
LNTO Stock Forecast | Lelantos Holdings | - |
0
|
$1.71 | Buy/Sell | $0.00 | -100.00% |
VIVC Stock Forecast | Vivic | - |
0
|
$0.75 | Buy/Sell | $0.00 | -100.00% |
Accenture PLC EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Accenture PLC's EBIT has grown by 55.47%, rising from $6.51B to $10.13B. For next year, analysts predict EBIT of $11.41B, which would mean an increase of 12.69%. Over the next seven years, experts predict that Accenture PLC's EBIT will grow at a rate of 110.99%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PCMC Stock Forecast | Public Company Management | - |
0
|
$0.11 | Buy/Sell | $0.00 | -100.00% |
HSTA Stock Forecast | Hestia Insight | - |
8
|
$0.16 | Buy/Sell | $0.00 | -100.00% |
HITC Stock Forecast | Healthcare Integrated Technolo... | - |
0
|
$0.07 | Buy/Sell | $0.00 | -100.00% |
Accenture PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Accenture PLC's EPS has fallen from $7.46 to $0.00 – a 100.00% decrease. In the next year, analysts expect EPS to reach $13.30 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
INVB Stock Forecast | InventaBioTech | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
AMMJ Stock Forecast | American Cannabis Company | - |
8
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
TSPG Stock Forecast | TGI Solar Power Group | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |